{"id":150890,"date":"2025-06-02T01:35:13","date_gmt":"2025-06-02T01:35:13","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/150890\/"},"modified":"2025-06-02T01:35:13","modified_gmt":"2025-06-02T01:35:13","slug":"uf-team-develops-ai-tool-to-make-genetic-research-more-comprehensive-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/150890\/","title":{"rendered":"UF team develops AI tool to make genetic research more comprehensive News"},"content":{"rendered":"<p>\u201cI thought to myself, \u2018I can fix that problem,\u2019\u201d said Graim, whose research centers around machine learning and precision medicine and who is trained in population genomics. \u201cIf our training data doesn\u2019t match our real-world data, we have ways to deal with that using machine learning. They\u2019re not perfect, but they can do a lot to address the issue.\u201d \u00a0<\/p>\n<p>By leveraging data from population genomics database gnomAD, PhyloFrame integrates massive databases of healthy human genomes with the smaller datasets specific to diseases used to train precision medicine models. The models it creates are better equipped to handle diverse genetic backgrounds. For example, it can predict the differences between subtypes of diseases like breast cancer and suggest the best treatment for each patient, regardless of patient ancestry.\u00a0<\/p>\n<p>&#13;<br \/>\n\t<img decoding=\"async\" style=\"width:225px;\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/06\/images.jpeg\"\/>&#13;<br \/>\n\t&#13;<br \/>\n      Kiley Graim, Ph.D.&#13;<br \/>\n  \t&#13;<\/p>\n<p>Processing such massive amounts of data is no small feat. The team uses UF\u2019s HiPerGator, one of the most powerful supercomputers in the country, to analyze genomic information from millions of people. For each person, that means processing 3 billion base pairs of DNA.\u00a0<\/p>\n<p>\u201cI didn\u2019t think it would work as well as it did,\u201d said Graim, noting that her doctoral student, Leslie Smith, contributed significantly to the study. \u201cWhat started as a small project using a simple model to demonstrate the impact of incorporating population genomics data has evolved into securing funds to develop more sophisticated models and to refine how populations are defined.\u201d\u00a0<\/p>\n<p>What sets PhyloFrame apart is its ability to ensure predictions remain accurate across populations by considering genetic differences linked to ancestry. This is crucial because most current models are built using data that does not fully represent the world\u2019s population. Much of the existing data comes from research hospitals and patients who trust the health care system. This means populations in small towns or those who distrust medical systems are often left out, making it harder to develop treatments that work well for everyone. \u00a0<\/p>\n<p>She also estimated 97% of the sequenced samples are from people of European ancestry, due, largely, to national and state level funding and priorities, but also due to socioeconomic factors that snowball at different levels \u2013 insurance impacts whether people get treated, for example, which impacts how likely they are to be sequenced.\u00a0<\/p>\n<p>\u201cSome other countries, notably China and Japan, have recently been trying to close this gap, and so there is more data from these countries than there had been previously but still nothing like the European data,&#8221; she said. \u201cPoorer populations are generally excluded entirely.\u201d\u00a0<\/p>\n<p>Thus, diversity in training data is essential, Graim said. \u00a0<\/p>\n<p>&#8220;We want these models to work for any patient, not just the ones in our studies,&#8221; she said. \u201cHaving diverse training data makes models better for Europeans, too. Having the population genomics data helps prevent models from overfitting, which means that they&#8217;ll work better for everyone, including Europeans.\u201d\u00a0<\/p>\n<p>Graim believes tools like PhyloFrame will eventually be used in the clinical setting, replacing traditional models to develop treatment plans tailored to individuals based on their genetic makeup. The team\u2019s next steps include refining PhyloFrame and expanding its applications to more diseases.\u00a0<\/p>\n<p>\u201cMy dream is to help advance precision medicine through this kind of machine learning method, so people can get diagnosed early and are treated with what works specifically for them and with the fewest side effects,\u201d she said. \u201cGetting the right treatment to the right person at the right time is what we\u2019re striving for.\u201d \u00a0<\/p>\n<p>Graim\u2019s project received funding from the UF College of Medicine Office of Research\u2019s AI2 Datathon grant award, which is designed to help researchers and clinicians harness AI tools to improve human health. \u00a0\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"\u201cI thought to myself, \u2018I can fix that problem,\u2019\u201d said Graim, whose research centers around machine learning and&hellip;\n","protected":false},"author":2,"featured_media":150891,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[267,70,16,15],"class_list":{"0":"post-150890","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114611206486975553","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/150890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=150890"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/150890\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/150891"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=150890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=150890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=150890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}